PL2129365T3 - Preparaty farmaceutyczne na bazie niepolarnych i polarnych lipidów do zastosowania oftalmicznego - Google Patents

Preparaty farmaceutyczne na bazie niepolarnych i polarnych lipidów do zastosowania oftalmicznego

Info

Publication number
PL2129365T3
PL2129365T3 PL07858130.3T PL07858130T PL2129365T3 PL 2129365 T3 PL2129365 T3 PL 2129365T3 PL 07858130 T PL07858130 T PL 07858130T PL 2129365 T3 PL2129365 T3 PL 2129365T3
Authority
PL
Poland
Prior art keywords
apolar
pharmaceutical formulations
polar lipids
formulations based
ophthalmic use
Prior art date
Application number
PL07858130.3T
Other languages
English (en)
Inventor
Maria Grazia Mazzone
Valeria Maria Carmela Moschetti
Fausto Giuseppe Miano
Letizia Gaetana Lo Grasso
Original Assignee
Sifi S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39027073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2129365(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sifi S.P.A. filed Critical Sifi S.P.A.
Publication of PL2129365T3 publication Critical patent/PL2129365T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07858130.3T 2007-03-30 2007-12-24 Preparaty farmaceutyczne na bazie niepolarnych i polarnych lipidów do zastosowania oftalmicznego PL2129365T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IT2007/000239 WO2008120249A1 (en) 2007-03-30 2007-03-30 Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
PCT/EP2007/064530 WO2008119401A1 (en) 2007-03-30 2007-12-24 Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use

Publications (1)

Publication Number Publication Date
PL2129365T3 true PL2129365T3 (pl) 2022-09-05

Family

ID=39027073

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07858130.3T PL2129365T3 (pl) 2007-03-30 2007-12-24 Preparaty farmaceutyczne na bazie niepolarnych i polarnych lipidów do zastosowania oftalmicznego

Country Status (10)

Country Link
US (1) US9161906B2 (pl)
EP (1) EP2129365B1 (pl)
CN (1) CN101657184A (pl)
AR (1) AR065861A1 (pl)
CL (1) CL2008000876A1 (pl)
ES (1) ES2914090T3 (pl)
MX (1) MX2009009839A (pl)
PL (1) PL2129365T3 (pl)
RU (1) RU2495661C2 (pl)
WO (2) WO2008120249A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007111806A2 (en) 2006-03-23 2007-10-04 Massachusetts Eye And Ear Infirmary Cyclopentane heptanoic acid compounds for reducing body fat
US9107815B2 (en) * 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
DE102009047764A1 (de) * 2009-12-10 2011-06-16 Evonik Goldschmidt Gmbh Trennmittel und Verwendung zur Herstellung von Kompositformkörpern
DE102010013081A1 (de) * 2010-03-26 2011-09-29 B. Braun Melsungen Ag Antimikrobielle Öl in Wasser Emulsion
WO2011127151A2 (en) * 2010-04-07 2011-10-13 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
SG187770A1 (en) 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
EP3378480A1 (en) 2011-01-19 2018-09-26 Topokine Therapeutics, Inc. Methods and compositions for treating obesity
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
US10238673B2 (en) * 2013-03-13 2019-03-26 Genetic Disease Investigators, LLC Methods and compositions for treatment of dry eye and correction of organ dysfunctions
NO2753788T3 (pl) 2013-05-10 2018-06-16
US9820993B2 (en) * 2013-05-15 2017-11-21 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
AU2015269353B2 (en) * 2014-06-04 2020-03-26 Tersus Pharmaceuticals, LLC Methods of treating chronic dry eye disease using C16:1n7 palmitoleate and derivatives thereof
US10188661B2 (en) 2014-06-27 2019-01-29 Topokine Therapeutics, Inc. Topical dosage regimen
CN106256351A (zh) * 2015-06-18 2016-12-28 江苏吉贝尔药业股份有限公司 盐酸奥洛他定凝胶滴眼液及其制备方法
WO2019108602A1 (en) 2017-11-28 2019-06-06 University Of Florida Research Foundation Methods and compositions for retinal drug delivery
AU2019248216A1 (en) * 2018-04-04 2020-11-12 Eye Co Pty Ltd Low THC hemp extract and method of treatment or prevention of an eye disease
WO2020250252A1 (en) 2019-06-11 2020-12-17 Sifi S.P.A. Microemulsion compositions
KR20240037272A (ko) * 2021-07-09 2024-03-21 주식회사 루카에이아이셀 건조 예방, 개선 또는 치료를 위한 지질 혼합물을 함유하는 점안액 및 이의 제조방법
WO2025022287A1 (en) * 2023-07-21 2025-01-30 Sonoclear As Uses of triglyceride and phospholipid compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
ATE132366T1 (de) * 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
AU680813B2 (en) * 1992-08-28 1997-08-14 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
AU1716995A (en) * 1994-03-18 1995-10-09 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
ES2265166T3 (es) * 1997-10-13 2007-02-01 R-Tech Ueno, Ltd. Composicion para tratamiento de hipertension intraocular o glaucoma.
JP2000143542A (ja) * 1998-11-10 2000-05-23 Wakamoto Pharmaceut Co Ltd 難溶性免疫抑制剤含有ｏ／ｗエマルジョン製剤
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
AU2002214233A1 (en) * 2001-11-01 2003-07-09 Novagali Pharma Sa Method and composition for dry eye treatment
DE60310039T2 (de) * 2002-02-07 2007-04-05 Pharmacia Corp. Pharmazeutische Tabletten
BR0311722A (pt) * 2002-06-13 2005-03-01 Novartis Ag Compostos de ciclodextrina com amÈnia quaternizado
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
CA2597590A1 (en) * 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US20070218007A1 (en) * 2006-03-17 2007-09-20 Allergan, Inc. Ophthalmic visualization compositions and methods of using same

Also Published As

Publication number Publication date
WO2008120249A1 (en) 2008-10-09
CN104771354A (zh) 2015-07-15
CL2008000876A1 (es) 2008-10-03
AR065861A1 (es) 2009-07-08
US9161906B2 (en) 2015-10-20
WO2008119401A1 (en) 2008-10-09
RU2495661C2 (ru) 2013-10-20
RU2009140073A (ru) 2011-05-10
EP2129365B1 (en) 2022-03-02
ES2914090T3 (es) 2022-06-07
CN101657184A (zh) 2010-02-24
US20100291226A1 (en) 2010-11-18
EP2129365A1 (en) 2009-12-09
MX2009009839A (es) 2009-12-08

Similar Documents

Publication Publication Date Title
PL2129365T3 (pl) Preparaty farmaceutyczne na bazie niepolarnych i polarnych lipidów do zastosowania oftalmicznego
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
EP2346520A4 (en) CURCUMINOIDS AND THEIR METABOLITES FOR OCULAR DISEASE APPLICATIONS
ZA201003195B (en) Aqueous ophthalmic formulations
IL202378A (en) Oxopyrazine history and herbicides containing them
IL199006A0 (en) Nanoparticulate formulations and methods for the making and use thereof
HUE069458T2 (hu) Terápiás hatóanyagok bejuttatására szolgáló új lipidek és készítmények
PL2131668T3 (pl) Ochronny hydrokoloid dla składników czynnych
GB0711656D0 (en) Formulations
ZA201004622B (en) Method for increasing the therapeutic efficacy if curcuminoids and analogues
PL2036882T3 (pl) Związki o jonach obojnaczych i ich zastosowanie
EP2044585A4 (en) SIMULATOR OF HUMAN MOVEMENT
EP2170085A4 (en) INSECT REPELLENT FORMULATIONS
ZA200907492B (en) Compositions for targeted imaging and therapy
EP2367444A4 (en) MEDICAL AND NUTRITIONAL FORMULATIONS
IL211670A0 (en) Therapeutic protein formulations
EP2160183A4 (en) QUETIPIN EXTENDED FORMULATIONS WITH EXTENDED RELEASE AND METHOD OF MANUFACTURING THEREOF
EP2120868A4 (en) LOW-DOSED MOMETASON FORMULATIONS
GB0711957D0 (en) Formulations
ZA200903049B (en) Polymer-linked-bisphosphonate inhalant formulations and methods for using the same
IL198160A0 (en) Pharmaceutical formulations
WO2009046453A9 (en) Use of neuregulin-1 in reducing brain damage
GB0705179D0 (en) Formulations
HK1171917A (en) Therapeutic vitamin d sun-protecting formulations and methods for their use
HK1159434A (en) Medical and nutritional formulations